Cargando…
Plague vaccines: current developments and future perspectives
Despite many decades of intensive studies of Yersinia pestis, the causative agent of plague, there is no safe and efficient vaccine against this devastating disease. A recently developed F1/V subunit vaccine candidate, which relies mainly on humoral immunity, showed promising results in animal studi...
Autores principales: | Feodorova, Valentina A, Motin, Vladimir L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630923/ https://www.ncbi.nlm.nih.gov/pubmed/26038406 http://dx.doi.org/10.1038/emi.2012.34 |
Ejemplares similares
-
Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine—Comparison of Immunoinformatic and Immunological Approaches
por: Feodorova, Valentina A., et al.
Publicado: (2020) -
Russian vaccines against especially dangerous bacterial pathogens
por: Feodorova, Valentina A, et al.
Publicado: (2014) -
Plague Prevention and Therapy: Perspectives on Current and Future Strategies
por: Rosario-Acevedo, Raysa, et al.
Publicado: (2021) -
Plague Vaccine Development: Current Research and Future Trends
por: Verma, Shailendra Kumar, et al.
Publicado: (2016) -
Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine
por: Feodorova, Valentina A., et al.
Publicado: (2018)